Personal information

Activities

Collapse all

Employment (3)

Essex Management: Essex, Vt, US

2022-11-28 to present | Lead Bioinformatician
Employment
Source: Self-asserted source
Matthew Pendleton

Oxford Nanopore Technologies (New York): New York City, NY, US

2017-10-02 to present | Bioinformatic Scientist (Genomic Applications)
Employment
Source: Self-asserted source
Matthew Pendleton

Regeneron Pharmaceuticals Inc: Tarrytown, NY, US

2008-01-01 to 2011-12-22 | Research Associate - Genome Engineering (VelocImmune Next)
Employment
Source: Self-asserted source
Matthew Pendleton

Education and qualifications (4)

Icahn School of Medicine at Mount Sinai: New York, NY, US

2012-08-22 to present | PhD Biomedical Science (Structural/Chemical Biology and Molecular Design)
Education
Source: Self-asserted source
Matthew Pendleton

University of Minnesota System: Minneapolis, MN, US

2005-08-01 to 2007-08-07 | MS Pharmacology (Pharmacology)
Education
Source: Self-asserted source
Matthew Pendleton

University of Wyoming: Laramie, WY, US

2003-08-23 to 2004-04-30 (Molecular Biology)
Education
Source: Self-asserted source
Matthew Pendleton

Gonzaga University: Spokane, WA, US

1999-08-25 to 2003-05-01 | MS (Biology)
Education
Source: Self-asserted source
Matthew Pendleton

Works (1)

Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing

Nature Biotechnology
2022-10 | Journal article
DOI: 10.1038/s41587-022-01289-z
Contributors: Aditya S. Deshpande; Netha Ulahannan; Matthew Pendleton; Xiaoguang Dai; Lynn Ly; Julie M. Behr; Stefan Schwenk; Will Liao; Michael A. Augello; Carly Tyer et al.
Source: check_circle
Crossref
How many people are using ORCID?